I) DTPa-HepB-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione.
I) et II) corresp. DTPa-HepB-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
Packungsbestandteile
II
Suspension injectable
BAG: Principe actif
Concentr.
Haemagglutinium Filamentosum (B. Pertussis)
25 mcg
Haemophilus Influenzae b Polysaccharida (Prp)
10 mcg
Pertactinum (B. Pertussis)
8 mcg
Toxoidum Diphtheriae
30 UI
Toxoidum Pertussis
25 mcg
Toxoidum Tetani
40 UI
Vaccinum Hepatitidis b (Adnr) Hbsag
10 mcg
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)
40 UI
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)
8 UI
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)
32 UI
Agents auxilliaires
Concentr.
Aluminii Phosphas
Conjugata cum Toxoido Tetani
10 µg
Lactosum
Polysaccharida Haemophili Influenzae Typus B
20752
I
Suspension injectable
Principe actif
Concentr.
Haemagglutininum Filamentosum (B. Pertussis)
25µg / 0.5ml
Hepatitidis b viri Antigenum Adnr
10µg / 0.5ml
Pertactinum (B. Pertussis)
8µg / 0.5ml
Toxoidum Diphtheriae
30U.I. / 0.5ml
Toxoidum Pertussis
25µg / 0.5ml
Toxoidum Tetani
40U.I. / 0.5ml
Virus Poliomyelitis Typus 1 Inactivatus (Mahoney)
40U.I. / 0.5ml
Virus Poliomyelitis Typus 2 Inactivatus (Mef1)
8U.I. / 0.5ml
Virus Poliomyelitis Typus 3 Inactivatus (Saukett)
32U.I. / 0.5ml
BAG: Principe actif
Concentr.
Haemagglutinium Filamentosum (B. Pertussis)
25 mcg
Haemophilus Influenzae b Polysaccharida (Prp)
10 mcg
Pertactinum (B. Pertussis)
8 mcg
Toxoidum Diphtheriae
30 UI
Toxoidum Pertussis
25 mcg
Toxoidum Tetani
40 UI
Vaccinum Hepatitidis b (Adnr) Hbsag
10 mcg
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)
40 UI
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)
8 UI
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)
32 UI
Agents auxilliaires
Concentr.
Aluminii Hydroxidum Hydricum ad Adsorptionem
Aluminii Phosphas
Medium
199
Sodium Chlorure
Source
Date de'limport en base : 08.11.2023
Enregistrement Swissmedic :
Séquence :
Nom du produit :
Titulaire de l'Autorisation: :
Groupe produit :
Index Therapeuticus (BSV) :
Code médicament :
Date d'enregistrement :
Valable jusqu'au: :
Numéro d'emballage :
Taille des présentations :
Forme commerciale/Unité :
Catégorie de livraison :
P. Actifs :
Composition :
